The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3)

EDITORIAL  PET/CT IMAGING IN AUTOIMMUNE DISORDERSFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):179-81

Update on PET/CT in autoimmune disorders

Lucia LECCISOTTI *, Olivier GHEYSENS

HTML PDF

REVIEW  PET/CT IMAGING IN AUTOIMMUNE DISORDERSFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):182-93

The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response

François JAMAR *, Lars C. GORMSEN, Halil YILDIZ, Riemer H. SLART, Kornelis S. van der GEEST, Olivier GHEYSENS

Abstract HTML PDF

REVIEW  PET/CT IMAGING IN AUTOIMMUNE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):194-205

The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren’s syndrome and systemic lupus erythematosus

Andrea GUARNERI, Elisabetta PERRONE, Silvia L. BOSELLO, Maria A. D’AGOSTINO, Lucia LECCISOTTI *

Abstract HTML PDF

REVIEW  PET/CT IMAGING IN AUTOIMMUNE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):206-17

The role of PET imaging in inflammatory bowel diseases: state-of-the-art review

Pierre LOVINFOSSE *, Roland HUSTINX

Abstract HTML PDF Supplementary_Materials

REVIEW  PET/CT IMAGING IN AUTOIMMUNE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):218-28

The role of PET/CT in thyroid autoimmune diseases

Elena CALIFARETTI, Sara DALL’ARMELLINA, Guido ROVERA, Monica FINESSI *, Désirée DEANDREIS

Abstract HTML PDF

REVIEW  PET/CT IMAGING IN AUTOIMMUNE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):229-33

The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella review

Barbara MUOIO, Domenico ALBANO, Francesco DONDI, Francesco BERTAGNA, Salvatore ANNUNZIATA, Francesco FIZ, Arnoldo PICCARDO, Ramin SADEGHI, Giorgio TREGLIA *

Abstract HTML PDF

REVIEW  PET/CT IMAGING IN AUTOIMMUNE DISORDERSFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):234-44

[18F]FDG PET/CT in rheumatoid arthritis

Richard N. GRAHAM *, Emmanouil PANAGIOTIDIS

Abstract HTML PDF

REVIEW  PET/CT IMAGING IN AUTOIMMUNE DISORDERSFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):245-54

Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging

Christos SACHPEKIDIS *, Jessica C. HASSEL, Antonia DIMITRAKOPOULOU-STRAUSS

Abstract HTML PDF

REVIEW  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):255-60

Nuclear cardiac imaging for the diagnosis and management of heart failure: what can be learned from recent guidelines?

Delphine M. VERVLOET, Johan de SUTTER *

Abstract PDF

REVIEW  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):261-71

Changes over the years in radiopharmaceutical design

William C. ECKELMAN, Torsten KUWERT, Andrea CIARMIELLO, Mattia RIONDATO *, Luigi MANSI

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):272-9

Fully integrated [18F]FDG PET/MR in large vessel vasculitis

Roberto PADOAN *, Filippo CRIMÌ, Mara FELICETTI, Federica PADOVANO, Carmelo LACOGNATA, Roberto STRAMARE, Emilio QUAIA, Diego CECCHIN, Franco BUI, Pietro ZUCCHETTA, Franco SCHIAVON

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):280-9

Benefit of including CT urography in [68Ga]PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis

Florian ROSAR *, Martin J. HÜGLE, Martin RIES, Mark BARTHOLOMÄ, Stephan MAUS, Peter FRIES, Fadi KHREISH, Samer EZZIDDIN

Abstract HTML PDF